Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iloperidone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102924439B details a novel one-step base catalytic method for Iloperidone. Achieves over 90% yield and 99% purity, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel water-based method for antipsychotic API intermediate Iloperidone offers high purity and reduced environmental impact compared to traditional DMF processes.
Patent CN102212063A reveals a novel two-step route for Iloperidone, offering superior purity and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN102395582A details aqueous alkaline synthesis yielding 99.5% purity. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Novel method for high-purity iloperidone preparation reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners seeking cost efficiency.
Patent CN102070626B details a novel two-step etherification route for Iloperidone, offering high purity and cost reduction in API manufacturing through improved regioselectivity.